logo
  

CDC Panel Backs Full Approval Of Pfizer-BioNTech COVID-19 Vaccine

U.S. Centers for Disease Control and Prevention advisory panel voted to recommend the use of the Pfizer and BioNTech COVID-19 vaccine for U.S. people 16 and older.

The recommendation came a week after the U.S. Food and Drug Administration granted full approval for the vaccine in the age group.

However, the vaccine's use in adolescents 12-15 will continue to have emergency authorization until more data accumulates.

last week, Pfizer said it sought an approval from the U.S. Food and Drug Administration for its booster dose of COVID-19 vaccine.

The Pfizer/BioNTech vaccine, marketed as Comirnaty, had been authorized for emergency use in the US since last December for people age 16 and older. In May, the authorization was extended to those 12 and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart is bringing back its month-long savings event "Black Friday Deals for Days" in November, with special early access for Walmart+ members. The retail behemoth, which reinvented the Black Friday shopping events last year, will spread out its Black Friday savings to three events throughout November. Each savings event will begin online at Walmart.com and continue with the same deals in stores. Shares of Philips Electronics NV were losing around 2 percent in the morning trading in Amsterdam after the Dutch consumer electronics giant on Monday trimmed its outlook for fiscal 2021 after reporting weak EBITA and sales in its third quarter. The results were hurt by supply chain challenges as well as Sleep & Respiratory Care recall. However, quarterly net profit was significantly higher. The Goldman Sachs Group, Inc. (GS) reported that its third quarter net earnings applicable to common shareholders increased 63 percent year-on-year. Net revenues were also significantly higher reflecting significantly higher net revenues in Investment Banking, Global Markets and Consumer & Wealth Management,...
Follow RTT